Mini Review
Published on 17 Feb 2023
Racing CARs to veterinary immuno-oncology
in Comparative and Clinical Medicine
Frontiers in Veterinary Science
doi 10.3389/fvets.2023.1130182
- 9,549 views
- 4 citations
16 articles related to "Single Chain Variable Fragment"
Articles
Original Research
Published on 12 May 2023
Docking guided phase display to develop fusion protein with novel scFv and alkaline phosphatase for one-step ELISA salbutamol detection
in Systems Microbiology
Frontiers in Microbiology
doi 10.3389/fmicb.2023.1190793
- 3,840 views
- 5 citations
Original Research
Published on 20 Dec 2021
TRAIL-R1-Targeted CAR-T Cells Exhibit Dual Antitumor Efficacy
in Molecular Diagnostics and Therapeutics
Frontiers in Molecular Biosciences
doi 10.3389/fmolb.2021.756599
- 6,114 views
- 10 citations
Original Research
Published on 23 Sep 2020
Intercellular Adhesion Molecule-1 as Target for CAR-T-Cell Therapy of Triple-Negative Breast Cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2020.573823
- 12,095 views
- 54 citations
Review
Published on 03 Apr 2017
Engineering Chimeric Antigen Receptor T-Cells for Racing in Solid Tumors: Don’t Forget the Fuel
in Molecular Innate Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2017.00267
- 23,706 views
- 73 citations
Original Research
Published on 12 Aug 2021
PTK7-Targeting CAR T-Cells for the Treatment of Lung Cancer and Other Malignancies
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2021.665970
- 18,165 views
- 55 citations
Original Research
Published on 19 Jul 2021
Monocyte Dysfunction Detected by the Designed Ankyrin Repeat Protein F7 Predicts Mortality in Patients Receiving Veno-Arterial Extracorporeal Membrane Oxygenation
in General Cardiovascular Medicine
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2021.689218
- 4,488 views
- 12 citations
Review
Published on 22 Nov 2017
Nanobodies and Nanobody-Based Human Heavy Chain Antibodies As Antitumor Therapeutics
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2017.01603
- 175,611 views
- 541 citations
Original Research
Published on 05 Jan 2023
The making of multivalent gamma delta TCR anti-CD3 bispecific T cell engagers
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2022.1052090
- 7,935 views
- 4 citations
Original Research
Published on 06 Jul 2023
Enhanced cytotoxicity of a Pseudomonas Exotoxin A based immunotoxin against prostate cancer by addition of the endosomal escape enhancer SO1861
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1211824
- 5,046 views
- 6 citations
Original Research
Published on 09 Mar 2026
Miniaturized IL-2/anti-IL-2 immunocytokines selectively activate and support the in vivo persistence of regulatory T cells
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2026.1755812
- 691 views
Original Research
Published on 02 Sep 2015
Diagnostic Potential of Recombinant scFv Antibodies Generated Against Hemagglutinin Protein of Influenza A Virus
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2015.00440
- 8,627 views
- 12 citations
Original Research
Published on 22 Feb 2023
Using the Jurkat reporter T cell line for evaluating the functionality of novel chimeric antigen receptors
in Molecular Medicine and Cancer Treatment
Frontiers in Molecular Medicine
doi 10.3389/fmmed.2023.1070384
- 32,476 views
- 28 citations
Original Research
Published on 11 Aug 2020
Diagnostic and Epitope Mapping Potential of Single-Chain Antibody Fragments Against Foot-and-Mouth Disease Virus Serotypes A, SAT1, and SAT3
in Veterinary Infectious Diseases
Frontiers in Veterinary Science
doi 10.3389/fvets.2020.00475
- 5,925 views
- 8 citations
Review
Published on 27 Apr 2017
FCγ Chimeric Receptor-Engineered T Cells: Methodology, Advantages, Limitations, and Clinical Relevance
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2017.00457
- 14,365 views
- 54 citations
Original Research
Published on 14 Oct 2022
Time-resolved fluorescence based direct two-site apoA-I immunoassays and their clinical application in patients with suspected obstructive coronary artery disease
in Coronary Artery Disease
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2022.912578
- 3,226 views